{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:48:23Z","timestamp":1781038103474,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693269"],"award-info":[{"award-number":["2021M693269"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18431907100"],"award-info":[{"award-number":["18431907100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107108"],"award-info":[{"award-number":["22107108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872725"],"award-info":[{"award-number":["81872725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejmech.2022.114608","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T21:56:34Z","timestamp":1657749394000},"page":"114608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold"],"prefix":"10.1016","volume":"240","author":[{"given":"Sheng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114608_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2022.114608_bib2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114608_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114608_bib4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in west africa - the first 9 Months of the epidemic and forward projections","volume":"371","author":"Aylward","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114608_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(19)31712-X","article-title":"Ebola outbreak declared a PHEIC, world waits for next steps","volume":"394","author":"Zarocostas","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114608_bib6","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1016\/j.cell.2021.09.035","article-title":"Pan-ebolavirus protective therapy by two multifunctional human antibodies","volume":"184","author":"Gilchuk","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114608_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/d41586-021-02378-w","article-title":"Ebola virus can lie low and reactivate after years in human survivors","volume":"597","author":"Garry","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","article-title":"Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks","volume":"597","author":"Keita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114608_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2020.03.011","article-title":"A vaccine against Ebola virus","volume":"181","author":"Ollmann Saphire","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114608_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2021.01.015","article-title":"Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein","volume":"54","author":"Misasi","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2022.114608_bib13","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.xphs.2020.09.011","article-title":"Preservation of quaternary structure in thermostable, lyophilized filovirus glycoprotein vaccines: a search for stability-indicating assays","volume":"109","author":"Preston","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114608_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114608_bib15","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","article-title":"Large-scale screening and identification of novel Ebola virus and marburg virus entry inhibitors","volume":"60","author":"Anantpadma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114608_bib16","doi-asserted-by":"crossref","first-page":"55750","DOI":"10.18632\/oncotarget.18498","article-title":"The lifecycle of the Ebola virus in host cells","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2022.114608_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib19","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1021\/acs.jmedchem.8b00350","article-title":"Structures of Ebola virus glycoprotein complexes with tricyclic antidepressant and antipsychotic drugs","volume":"61","author":"Zhao","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib20","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acs.jmedchem.8b01328","article-title":"Structure-based in silico screening identifies a potent ebolavirus inhibitor from a traditional Chinese medicine library","volume":"62","author":"Shaikh","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-020-03146-y","article-title":"Ebola virus antibody decay-stimulation in a high proportion of survivors","volume":"590","author":"Adaken","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib22","doi-asserted-by":"crossref","first-page":"113654","DOI":"10.1016\/j.ejmech.2021.113654","article-title":"Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction","volume":"223","author":"Morales-Tenorio","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib23","doi-asserted-by":"crossref","first-page":"112726","DOI":"10.1016\/j.ejmech.2020.112726","article-title":"Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process","volume":"207","author":"Sokolova","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib24","doi-asserted-by":"crossref","first-page":"112595","DOI":"10.1016\/j.ejmech.2020.112595","article-title":"Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein","volume":"204","author":"Gao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib25","doi-asserted-by":"crossref","first-page":"105011","DOI":"10.1016\/j.antiviral.2021.105011","article-title":"Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses","volume":"186","author":"Lasala","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2022.114608_bib26","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1021\/acs.jmedchem.0c01001","article-title":"Screening and reverse-engineering of estrogen receptor ligands as potent pan-filovirus inhibitors","volume":"63","author":"Cooper","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114608_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acsmedchemlett.0c00025","article-title":"Discovery of adamantane carboxamides as Ebola virus cell entry and glycoprotein inhibitors","volume":"11","author":"Plewe","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114608_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","article-title":"Target identification and mode of action of four chemically divergent drugs against ebolavirus infection","volume":"61","author":"Ren","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib30","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acs.jmedchem.8b00704","article-title":"Identification of potent Ebola virus entry inhibitors with suitable properties for in vivo studies","volume":"61","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib31","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1021\/acs.jmedchem.0c00463","article-title":"Discovery and structural optimization of 4-(aminomethyl)benzamides as potent entry inhibitors of Ebola and marburg virus infections","volume":"63","author":"Gaisina","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib32","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/S0040-4039(00)77633-7","article-title":"Towards the synthesis of hiv-protease inhibitors - synthesis of optically pure 3-carboxyl-decahydroisoquinolines","volume":"34","author":"Houpis","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114608_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2533\/chimia.1996.532","article-title":"Synthesis of the HIV-proteinase inhibitor Saquinavir: a challenge for process research","volume":"50","author":"Gohring","year":"1996","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2022.114608_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3987\/COM-05-10571","article-title":"Derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid","volume":"68","author":"Jansa","year":"2006","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2022.114608_bib35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1248\/cpb.56.1147","article-title":"Synthesis and biological evaluation of novel isopropanolamine derivatives as non-peptide human immunodeficiency virus protease inhibitors","volume":"56","author":"Zhou","year":"2008","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2022.114608_bib36","series-title":"Process for Producing Optically Active Amides","author":"Takahiro","year":"1997"},{"key":"10.1016\/j.ejmech.2022.114608_bib37","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1021\/jm900563e","article-title":"Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues","volume":"52","author":"Marquis","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/jm501814x","article-title":"2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents","volume":"58","author":"Bardiot","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/cb500843r","article-title":"HIV protease inhibitors block streptolysin S production","volume":"10","author":"Maxson","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114608_bib40","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1021\/ja9009265","article-title":"Total synthesis of the sphingolipid biosynthesis inhibitor fumonisin B(1)","volume":"131","author":"Pereira","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114608_bib41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.tetasy.2012.06.003","article-title":"Enantioselective synthesis of HIV protease inhibitor amprenavir via Co-catalyzed HKR of 2-(1-azido-2-phenylethyl)oxirane","volume":"23","author":"Gadakh","year":"2012","journal-title":"Tetrahedron Alert"},{"key":"10.1016\/j.ejmech.2022.114608_bib42","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1021\/jm050019i","article-title":"Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors","volume":"48","author":"Ghosh","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib43","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1055\/s-0032-1316805","article-title":"Stereo- and regioselective synthesis of 2-Amino-3,5-diols via stereospecific crotyl transfer and regioselective aminohydroxylation","volume":"44","author":"McDonald","year":"2012","journal-title":"Synthesis-Stuttgart"},{"key":"10.1016\/j.ejmech.2022.114608_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejmech.2013.07.001","article-title":"Total synthesis and biological evaluation of clavaminol-G and its analogs","volume":"67","author":"Vijai Kumar Reddy","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib45","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1021\/acs.jmedchem.0c01348","article-title":"Triterpenoid-mediated inhibition of virus-host interaction: is now the time for discovering viral entry\/release inhibitors from nature?","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114608_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8408","article-title":"Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes","volume":"4","author":"Si","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2022.114608_bib47","series-title":"Process for the Preparation of 3-substituted 1,2,3,4-tetrahydro Isoquinoline Derivatives","author":"Surendra","year":"1993"},{"key":"10.1016\/j.ejmech.2022.114608_bib48","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2022.114608_bib49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:34Z","timestamp":1759329994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422005104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":49,"alternative-id":["S0223523422005104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114608","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114608"}}